Afnan Alsultan

Afnan Alsultan

Auto-generated profile, based on publicly available information

Afnan Alsultan

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
LYLamya Zohair Yamani
Lamya Zohair Yamani
AAAisha AlAmri
Aisha AlAmri
AAAfnan Alsultan
Afnan Alsultan
SASomaya Alfifi
Somaya Alfifi
MAMohammad Azam Ansari
Mohammad Azam Ansari
AAAmani Alnimr
Amani Alnimr

10 December 2025 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
FHFath-alrahman Hassan
Fath-alrahman Hassan
AAAfnan Alsultan
Afnan Alsultan
WAWaleed Albuali
Waleed Albuali
DBDalal Bubshait
Dalal Bubshait
EAElfadil Abass
Elfadil Abass
FAFaisal M. Alzahrani
Faisal M. Alzahrani
Purpose: This study investigates the association between single nucleotide polymorphism in RPL5 and the risk of deep vein thrombosis (DVT) in the Saudi population. Materials and methods: The case-control study included 98 DVT patients and 97 age- and sex-matched healthy controls. Peripheral blood samples were collected for genetic analysis after ethical clearance. DNA extraction was performed using a standard protocol, and RPL5 gene primers were designed for PCR amplification. Sanger sequencing was performed using the ABI 3730×L system. Results: Findings showed a significant correlation between DVT patients and controls for two alleles: RPL5 rs558220259 G (p = 0.000); rs576892621 G (p = 0.031). Genotype analysis showed significant associations for rs138979590 (C/T) (p = 0.0001), rs558220259 (G/A) (p = 0.0087), and rs576892621 (G/A) (p = 0.0272) with DVT. Conclusions: Our findings indicate that variants (rs138979590, rs558220259, and rs576892621) significantly contribute to DVT risk in Saudi patients.

1 December 2025 in International Journal of Innovative Research and Scientific Studies
Verified
Journal Article
Open access
MAManar Alzahrani
Manar Alzahrani
AAAfnan Alsultan
Afnan Alsultan
AAAisha AlAmri
Aisha AlAmri
RARawabi Aldossary
Rawabi Aldossary
LYLamya Zohair Yamani
Lamya Zohair Yamani
EAElfadil Abass
Elfadil Abass
This study aimed to investigate the serological responses to COVID-19 vaccines in the Saudi population post pandemic, a period characterized by presumed hybrid immunity, and to assess demographic and clinical factors influencing antibody responses. IgG antibody responses to the SARS-CoV-2 spike protein were assessed using chemiluminescent immunoassay (CLIA) in 401 individuals from the Saudi population. Of the 401 participants, 395 were vaccinated and 397 (99%) were positive for anti-SARS-CoV spike protein antibodies, including five of the six unvaccinated individuals. Antibody positivity peaked in ages 20-29 and was lowest in children (0-9 years) and adults over 80 years. IgG levels differed between vaccinated and unvaccinated participants (P < 0.0001) and between sexes (P = 0.0072), but not by vaccine type, dose, or comorbidities. Unexpectedly, vaccinated individuals without prior infection had higher IgG than those with prior infection, challenging the presumed advantage of hybrid immunity. In this Saudi cohort, age and sex significantly influenced spike IgG responses, while vaccine type, dosage, and comorbidities had no effect. Unexpectedly, hybrid immunity showed no advantage, indicating altered immune dynamics at the pandemic’s end. These findings provide valuable insights into population-level COVID-19 immunity and can inform public health strategies and vaccine policies in settings with widespread prior infection or vaccination.